NL-OMON33759尚未招募4 期
PHARMACOGENOMIC AND PHARMACOKINETIC SAFETY AND COST-SAVING ANALYSIS IN PATIENTS TREATED WITH FLUOROPYRIMIDINES - Pharmacogenomic guided dosing of fluoropyrimidines
Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 500 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Patient is considered for treatment with capecitabine or 5-FU
- •- Age 18 years or older
- •- Able and willing to undergo blood sampling for pharmacogenetic and pharmacokinetic analysis
- •- Life expectancy more than 2 months allowing adequate follow up of toxicity evalution and antitumor activity
- •- Minimal acceptable safety laboratory values
- •- WHO performance status of 0 - 2
- •- No radio- or chemotherapy within the last 3 weeks prior to study entry
排除标准
- •- Patients with known alcoholism, drug addiction and/or psychotic disorders in the history that are not suitable for adequate follow up.
- •- Women who are pregnant, breast feeding or women of childbearing potential who refuse to use a reliable contraceptive method throughout the study.
研究者
相似试验
进行中（未招募）
不适用
PHARMACOGENOMIC AND PHARMACOKINETIC SAFETY AND COST-SAVING ANALYSIS IN PATIENTS TREATED WITH FLUOROPYRIMIDINESEUCTR2007-000412-82-NLKI-AV500
进行中（未招募）
1 期
ACTIVITY AND SAFETY OF APIXABAN IN PATIENTS IN HEMODAFILTRATIOEUCTR2019-002353-29-ESHOSPITAL UNIVERSITARI DE BELLVITGE- IDIBE20
尚未招募
1 期
Phase 1a study of VGA039 in healthy volunteers and patients with von Willebrand diseaseCTRI/2024/04/065934Vega Therapeutics, Inc
撤回
1 期
Safety and tolerability of an inhaled chelator in combination with antibiotic treatment for lung infection in patients with cystic fibrosisRespiratory - Other respiratory disorders / diseasescystic fibrosisACTRN12618001715268Telethon Kids Institute24
进行中（未招募）
1 期
A study to investigate whether RO707049389 is safe and how it is processed by the body, and its antiviral effect at different dose levels and in different population (healthy people, patients infected with hepatitis B virus and patients had chronic active hepatitis B)Chronic Hepatitis BMedDRA version: 20.1Level: PTClassification code 10008910Term: Chronic hepatitis BSystem Organ Class: 10021881 - Infections and infestationsEUCTR2019-001139-30-BGF. Hoffman-La Roche Ltd.192